Find out why coding for primary source of tumor is as important as coding for the tumor itself. Malignant lungs/bronchial tumor and pleural effusion are two of the most common diagnosis in pulmonology. If your mind is set a year back in time for these conditions, you could easily mix up the old and new ways of coding them. For instance, you now need to be on the lookout for the source of a primary tumor when coding pleural effusions. Check out if you've got the answers for the quiz right. 209.21, 209.61 End Scrambling for Dx Code on Different Tumor Types Scenario 1: The pulmonologist performs bronchial biopsies on a mass in a patient's upper bronchus. Pathology reports come back indicating a malignant carcinoid tumor. What should you report? Solution 1: You'll often use 209.21 or 209.61 on your lung biopsy claims. These could be repeat biopsies in which you already have a diagnosis, or initial biopsies in which the physician is unsure of the patient's status. In the past: 511.81: Don't Forget Fifth Digit in Malignant Pleural Effusion Coding Scenario 2: X-ray results brought to the pulmonologist's office indicate that the patient has a probable malignant pleural effusion. The pulmonologist performs a thoracentesis with tube on a patient with malignant cancer of the main bronchus. What codes would you bill in this case? Solution 2: Caution: A malignant pleural effusion is caused by a cancerous invasion of the pleura. This could be due to cancer within the lung or metastatic disease from any other organ (such as the colon or kidney), says Alan L. Plummer, MD, professor of medicine, Division of Pulmonary, Allergy, and Critical Care at Emory University School of Medicine in Atlanta. When the patient has a pleural effusion that does not include cancer or tuberculosis, you would bill 511.89 (Other specified forms of effusion, except tuberculosis) on your claim. In the past: